A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Status: Recruiting
Location: See all (158) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Maximum Age: 90
Healthy Volunteers: f
View:

∙ \- A diagnosis of Alzheimer's disease (AD) in accordance with the 2024 Alzheimer's Association criteria with one of the following confirmations of AD pathology: i) Historical evidence of AD diagnosis with amyloid positron emission tomography (PET), Aβ42/40 ratio in CSF, pTau181/Aβ42 ratio in CSF or pTau217/Aβ42 ratio in plasma using an Health Authority (HA)-authorized diagnostic assay.

∙ ii) If no historical evidence available: A. A plasma biomarker will be assessed for eligibility if allowed per regulatory requirements. The test cutoff(s) will be based on diagnostic use approval.

∙ B. If a plasma biomarker assay cannot be used or if the assay result is inconclusive, conduct one the following:

• Amyloid PET.

• Aβ42/40 ratio or pTau181/Aβ42 ratio in CSF using an HA-authorized diagnostic assay.

‣ Mini-Mental State Examination (MMSE) score of 5 to 22, inclusive, at Screening (Visit 1).

⁃ Have one identified caregiver who should have sufficient contact (approximately 10 hours a week or more) and is willing to:

‣ i) Attend all visits and report on participant's status. ii) Oversee participant compliance with medication and study procedures. iii) Participate in the study assessments and provide informed consent to participate in the study.

⁃ History of agitation that meets the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders with onset at least two weeks prior to Screening (Visit 1).

⁃ AD participants are required to have NPI/NPI-NH Agitation/Aggression score ≥ 4 at Screening (Visit 1) and Baseline (Visit 2).

⁃ CGI-S ≥ 4, as related to agitation, at Screening (Visit 1) and Baseline (Visit 2).

⁃ At least 1 of the following 3 criteria must be established from the CMAI-IPA at Screening (Visit 1) and Baseline (Visit 2; CMAI-IPA Physical/Verbal Aggression Positivity):

‣ i) 1 or more aggressive behaviors occurring at least several times per week. ii) 2 or more aggressive behaviors occurring at least once or twice per week. iii) 3 or more aggressive behaviors occurring less than once per week.

Locations
United States
Arizona
Imaging Endpoints
RECRUITING
Scottsdale
California
Advanced Research Center (ARC) - Anaheim
RECRUITING
Anaheim
Kaizen Brain Center
RECRUITING
La Jolla
Local Institution - 1662
NOT_YET_RECRUITING
Pomona
Torrance Clinical Research
RECRUITING
Torrance
Sunwise Clinical Research
RECRUITING
Walnut Creek
Colorado
Local Institution - 1630
WITHDRAWN
Colorado Springs
Florida
Local Institution - 1622
NOT_YET_RECRUITING
Maitland
Local Institution - 1631
NOT_YET_RECRUITING
Maitland
Hope Research Network - Miami
RECRUITING
Miami
Local Institution - 1602
NOT_YET_RECRUITING
Miami
Local Institution - 1618
NOT_YET_RECRUITING
Miami
Nuovida Research Center
RECRUITING
Miami
Local Institution - 1608
NOT_YET_RECRUITING
Ocala
Combined Research Orlando (CRO)
RECRUITING
Orlando
Progressive Medical Research
RECRUITING
Port Orange
Georgia
Local Institution - 1661
NOT_YET_RECRUITING
Savannah
Louisiana
Local Institution - 1655
NOT_YET_RECRUITING
Marrero
Massachusetts
Local Institution - 1663
NOT_YET_RECRUITING
Foxborough
Boston Center for Memory
RECRUITING
Newton
Mayflower Clinical Research
RECRUITING
South Dartmouth
Local Institution - 1660
NOT_YET_RECRUITING
Springfield
Maryland
CBH Health
RECRUITING
Gaithersburg
Michigan
Local Institution - 1665
NOT_YET_RECRUITING
Bloomfield Hills
Oakland Medical Research
RECRUITING
Troy
North Carolina
Local Institution - 1601
NOT_YET_RECRUITING
Monroe
New Jersey
Patient First MD
RECRUITING
Middletown
Local Institution - 1664
NOT_YET_RECRUITING
Princeton
Nevada
Redbird Research
RECRUITING
Las Vegas
New York
Local Institution - 1610
NOT_YET_RECRUITING
Inwood
Local Institution - 1656
NOT_YET_RECRUITING
New Windsor
Local Institution - 1645
WITHDRAWN
Woodmere
Local Institution - 1658
NOT_YET_RECRUITING
Woodmere
Ohio
Local Institution - 1659
NOT_YET_RECRUITING
Centerville
Oklahoma
Central States Research
RECRUITING
Tulsa
South Carolina
Local Institution - 1652
WITHDRAWN
Columbia
Local Institution - 1653
NOT_YET_RECRUITING
Columbia
Texas
Advanced Neurology Epilepsy and Sleep Center
RECRUITING
El Paso
Utah
Wasatch Clinical Research, LLC
RECRUITING
Salt Lake City
Vermont
Local Institution - 1646
NOT_YET_RECRUITING
Bennington
Washington
Local Institution - 1644
NOT_YET_RECRUITING
Seattle
Kingfisher Cooperative
RECRUITING
Spokane
Other Locations
Argentina
Local Institution - 1003
NOT_YET_RECRUITING
Buenos Aires
Local Institution - 1000
NOT_YET_RECRUITING
Córdoba
Local Institution - 1004
NOT_YET_RECRUITING
Córdoba
Local Institution - 1005
NOT_YET_RECRUITING
Córdoba
Local Institution - 1001
NOT_YET_RECRUITING
La Plata
Local Institution - 1002
NOT_YET_RECRUITING
Mar Del Plata
Local Institution - 1006
NOT_YET_RECRUITING
Rosario
Brazil
Local Institution - 1051
NOT_YET_RECRUITING
Brasília
Local Institution - 1057
NOT_YET_RECRUITING
Campinas
Local Institution - 1052
NOT_YET_RECRUITING
Curitiba
Local Institution - 1053
NOT_YET_RECRUITING
Curitiba
Local Institution - 1054
NOT_YET_RECRUITING
Porto Alegre
Local Institution - 1058
NOT_YET_RECRUITING
Porto Alegre
Local Institution - 1050
NOT_YET_RECRUITING
Rio De Janeiro
Local Institution - 1055
NOT_YET_RECRUITING
São Paulo
Local Institution - 1056
NOT_YET_RECRUITING
São Paulo
Bulgaria
Local Institution - 1101
NOT_YET_RECRUITING
Pleven
Local Institution - 1103
NOT_YET_RECRUITING
Razgrad
Local Institution - 1100
NOT_YET_RECRUITING
Sofia
Local Institution - 1102
NOT_YET_RECRUITING
Varna
Canada
Local Institution - 1153
NOT_YET_RECRUITING
Hamilton
Local Institution - 1155
NOT_YET_RECRUITING
London
Local Institution - 1755
WITHDRAWN
London
Local Institution - 1150
NOT_YET_RECRUITING
Montreal
Local Institution - 1151
NOT_YET_RECRUITING
Toronto
Local Institution - 1154
NOT_YET_RECRUITING
Toronto
Ontario Shores Centre For Mental Health Sciences
RECRUITING
Whitby
China
Local Institution - 1805
NOT_YET_RECRUITING
Beijing
Local Institution - 1810
NOT_YET_RECRUITING
Beijing
Local Institution - 1803
NOT_YET_RECRUITING
Changsha
Local Institution - 1819
NOT_YET_RECRUITING
Chengdu
Local Institution - 1813
NOT_YET_RECRUITING
Chongqing
Local Institution - 1802
NOT_YET_RECRUITING
Guangzhou
Local Institution - 1809
NOT_YET_RECRUITING
Guangzhou
Local Institution - 1815
NOT_YET_RECRUITING
Haidian District
Local Institution - 1804
NOT_YET_RECRUITING
Hangzhou
Local Institution - 1817
NOT_YET_RECRUITING
Hangzhou
Local Institution - 1812
NOT_YET_RECRUITING
Kunming
Local Institution - 1801
NOT_YET_RECRUITING
Nanjing
Local Institution - 1800
NOT_YET_RECRUITING
Shanghai
Local Institution - 1818
NOT_YET_RECRUITING
Shenzhen
Local Institution - 1808
NOT_YET_RECRUITING
Tianjin
Local Institution - 1814
NOT_YET_RECRUITING
Tianjin
Local Institution - 1816
NOT_YET_RECRUITING
Xian
Croatia
Local Institution - 1554
NOT_YET_RECRUITING
Rijeka
Local Institution - 1551
NOT_YET_RECRUITING
Split
Local Institution - 1552
NOT_YET_RECRUITING
Varaždin
Local Institution - 1550
NOT_YET_RECRUITING
Zagreb
Local Institution - 1553
NOT_YET_RECRUITING
Zagreb
Greece
Local Institution - 1202
NOT_YET_RECRUITING
Athens
Local Institution - 1203
NOT_YET_RECRUITING
Athens
Local Institution - 1205
NOT_YET_RECRUITING
Athens
Local Institution - 1206
NOT_YET_RECRUITING
Athens
Local Institution - 1207
NOT_YET_RECRUITING
Athens
Local Institution - 1201
NOT_YET_RECRUITING
Ioannina
Local Institution - 1200
NOT_YET_RECRUITING
Pátrai
Local Institution - 1204
NOT_YET_RECRUITING
Thessaloniki
India
Local Institution - 1255
NOT_YET_RECRUITING
Ahmedabad
Local Institution - 1256
NOT_YET_RECRUITING
Delhi
Local Institution - 1251
NOT_YET_RECRUITING
Hyderabad
Local Institution - 1252
NOT_YET_RECRUITING
Hyderabad
Local Institution - 1250
NOT_YET_RECRUITING
Kolkata
Local Institution - 1253
NOT_YET_RECRUITING
New Delhi
Local Institution - 1254
NOT_YET_RECRUITING
Varanasi
Japan
Local Institution - 1305
NOT_YET_RECRUITING
Bunkyo-ku
Local Institution - 1302
NOT_YET_RECRUITING
Fukuoka
Local Institution - 1301
NOT_YET_RECRUITING
Hadano
Local Institution - 1303
NOT_YET_RECRUITING
Kanzaki-gun Yoshinogari-cho
Local Institution - 1300
NOT_YET_RECRUITING
Karatsu-shi
Local Institution - 1307
NOT_YET_RECRUITING
Kawasaki
Local Institution - 1306
NOT_YET_RECRUITING
Okayama
Local Institution - 1304
NOT_YET_RECRUITING
Sakai
Local Institution - 1308
NOT_YET_RECRUITING
Shimotsuke-shi, Tochigi
Mexico
Local Institution - 1356
NOT_YET_RECRUITING
Mexico City
Local Institution - 1360
NOT_YET_RECRUITING
Mexico City
Local Institution - 1361
NOT_YET_RECRUITING
Mexico City
Local Institution - 1363
NOT_YET_RECRUITING
Mexico City
Local Institution - 1350
NOT_YET_RECRUITING
Monterrey
Local Institution - 1364
NOT_YET_RECRUITING
Monterrey
Local Institution - 1355
NOT_YET_RECRUITING
Saltillo
Local Institution - 1362
NOT_YET_RECRUITING
San Luis Potosí City
Local Institution - 1352
NOT_YET_RECRUITING
Tlalnepantla
Portugal
Local Institution - 1401
NOT_YET_RECRUITING
Coimbra
Local Institution - 1402
NOT_YET_RECRUITING
Guimarães
Local Institution - 1404
NOT_YET_RECRUITING
Lisbon
Local Institution - 1403
NOT_YET_RECRUITING
Senhora Da Hora
Campus Neurologico Senior
RECRUITING
Torres Vedras
Romania
Local Institution - 1450
NOT_YET_RECRUITING
Bucharest
Local Institution - 1451
NOT_YET_RECRUITING
Bucharest
Local Institution - 1453
NOT_YET_RECRUITING
Bucharest
Local Institution - 1454
NOT_YET_RECRUITING
Bucharest
Local Institution - 1458
NOT_YET_RECRUITING
Bucharest
Local Institution - 1459
NOT_YET_RECRUITING
Bucharest
Prof. Dr. Alexandru Obregia Psychiatry Hospital
RECRUITING
Bucharest
Prof. Dr. Alexandru Obregia Psychiatry Hospital
RECRUITING
Bucharest
Prof. Dr. Alexandru Obregia Psychiatry Hospital
RECRUITING
Bucharest
Local Institution - 1461
NOT_YET_RECRUITING
Constanța
Local Institution - 1457
NOT_YET_RECRUITING
Iași
Local Institution - 1460
NOT_YET_RECRUITING
Sanpetru /brasov
Local Institution - 1462
NOT_YET_RECRUITING
Sibiu
Spain
Local Institution - 1509
NOT_YET_RECRUITING
Elche (alicante)
Local Institution - 1510
NOT_YET_RECRUITING
Getxo
Hospital Clinico San Carlos
RECRUITING
Madrid
Local Institution - 1508
NOT_YET_RECRUITING
Madrid
Hospital Clinico Universitario Virgen de La Victoria
RECRUITING
Málaga
Local Institution - 1507
NOT_YET_RECRUITING
Pamplona
Local Institution - 1500
NOT_YET_RECRUITING
Salamanca
Local Institution - 1503
NOT_YET_RECRUITING
Seville
Local Institution - 1504
NOT_YET_RECRUITING
Terrassa
Local Institution - 1506
NOT_YET_RECRUITING
Valladolid
Local Institution - 1501
NOT_YET_RECRUITING
Zaragoza
Taiwan
Local Institution - 1753
NOT_YET_RECRUITING
Kaohsiung Niao Sung Dist
Local Institution - 1751
NOT_YET_RECRUITING
Tainan, Taiana
Local Institution - 1750
NOT_YET_RECRUITING
Taipei
Local Institution - 1754
NOT_YET_RECRUITING
Taipei
Local Institution - 1752
NOT_YET_RECRUITING
Taoyuan District
Contact Information
Primary
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Clinical.Trials@bms.com
855-907-3286
Backup
First line of the email MUST contain the NCT# and Site #.
Time Frame
Start Date: 2025-07-10
Estimated Completion Date: 2028-12-08
Participants
Target number of participants: 352
Treatments
Experimental: KarXT + KarX-EC
Placebo_comparator: Placebo
Related Therapeutic Areas
Sponsors
Leads: Bristol-Myers Squibb

This content was sourced from clinicaltrials.gov